Source: MarketScreener

CorWave: CorWave : Successfully Performed a 90-Day In Vivo Study on Its Revolutionary Cardiac Pump Synchronized With the Native Heart, Results Presented at ASAIO Meeting

(marketscreener.com) CorWave, a French medical device company committed to the fight against heart failure, announced that it has successfully completed the first 90-day preclinical study to evaluate its left ventricular assist device operating synchronously with the native heart without the use of sensors. The results were presented at the American Society for...https://www.marketscreener.com/news/latest/CorWave-nbsp-Successfully-Performed-a-90-Day-In-Vivo-Study-on-Its-Revolutionary-Cardiac-Pump-Synch--35598697/?utm_medium=RSS&utm_content=20210614

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Louis de Lillers's photo - CEO of CorWave

CEO

Louis de Lillers

CEO Approval Rating

78/100

Read more